CARIS LIFE SCIENCES, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
CARIS LIFE SCIENCES, INC. (CAI) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$362.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$362.00K, a 185.38% decline year-over-year.
- CARIS LIFE SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$44.00K, a 309.52% decline year-over-year.
- CARIS LIFE SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $182.00K, a 3540.00% increase year-over-year.
- CARIS LIFE SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $71.00K.
- CARIS LIFE SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $698.00K.
- CARIS LIFE SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$8.00K.
- CARIS LIFE SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was -$1.48M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$362.00K 10-Q · filed 2026-08-05 | -$406.00K 10-Q · filed 2026-08-05 | -$224.00K derived: sum of 3 quarters · filed 2026-08-05 | -$153.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$44.00K 10-Q · filed 2026-05-08 | $138.00K derived: sum of 2 quarters · filed 2026-05-08 | $209.00K derived: sum of 3 quarters · filed 2026-05-08 | $633.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $253.00K derived: sum of 2 quarters · filed 2026-03-03 | $677.00K derived: sum of 3 quarters · filed 2026-08-05 | $698.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $71.00K 10-Q · filed 2025-11-05 | $495.00K derived: sum of 2 quarters · filed 2026-08-05 | $516.00K 10-Q · filed 2025-11-05 | $521.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $424.00K 10-Q · filed 2026-08-05 | $445.00K 10-Q · filed 2026-08-05 | $450.00K derived: sum of 3 quarters · filed 2026-08-05 | $330.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $21.00K 10-Q · filed 2026-05-08 | $26.00K derived: sum of 2 quarters · filed 2026-05-08 | -$94.00K derived: sum of 3 quarters · filed 2026-05-08 | -$2.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$115.00K derived: sum of 2 quarters · filed 2026-03-03 | -$23.00K derived: sum of 3 quarters · filed 2026-03-03 | -$8.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | -$120.00K 10-Q · filed 2025-11-05 | -$28.00K derived: sum of 2 quarters · filed 2025-11-05 | -$13.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $92.00K 10-Q · filed 2025-08-12 | $107.00K 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | -$1.48M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |